ADAM17 and neoplasm: A disintegrin and metalloprotease 17 (ADAM17), another protein associated with chemoresistance, enhances tumor cell proliferation and survival via the epidermal growth factor receptor (EGFR) pathway by cleaving various ligands such as amphiregulin (AREG).